News and Press Releases

PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine

VE303 was well tolerated and decreased the odds of rCDI through multiple mechanisms Analyses identified predictors of VE303 colonization and protection from CDI recurrence Topline data for the ongoing Phase...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: January 23, 2025

19 Blackstone Street Cambridge, MA 02139

Spektus Pharma and Recipharm Announce Strategic Partnership to Develop and Supply CNS Medicines Using Flexitab™ Oral Drug Delivery Platform

22 January 2025 -- Montreal, Canada -- Spektus Pharma, an innovator in value added medicine development, and Recipharm, a leading global contract development and manufacturing organization, have entered into a...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 22, 2025

ACG to Showcase Sustainable Packaging Innovations at Pharmapack Paris 2025

Welcomes Jochen Scheil as Head of Global Sales for ACG Packaging Materials 21 January 2025 -- Paris, France -- ACG, the world’s leading supplier of integrated solutions for the pharmaceutical...

Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 21, 2025

D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN

Advarra Introduces Comprehensive Solution to Accelerate Study Startup and Improve Collaboration on Trials

Proven technology powers end-to-end solution designed to streamline site activation workflows, improve engagement, and optimize visibility among trial stakeholders 21 January 2025 -- Maryland, US -- Advarra, the market leader...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: January 21, 2025

6100 Merriweather Dr., Suite 600 Columbia, MD 21044

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis Programme delivered by CF AMR Syndicate offers cross-sector collaboration and...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 21, 2025

11 The Square University Of Glasgow University Avenue Glasgow G12 8QQ

European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer

Latest topline data from the Phase 3 MARIPOSA study shows amivantamab plus lazertinib is the first regimen to demonstrate superior overall survival benefit compared to the current standard of care...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 21, 2025

Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG

Opella reaches study milestone for Cialis

21 January 2025 -- Paris, France -- Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual...

Category: Clinical Trials, Other, Pharmaceutical
Posted: January 21, 2025

One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis Programme delivered by CF AMR Syndicate offers cross-sector collaboration and...

Category:
Posted: January 21, 2025

11 The Square University Of Glasgow University Avenue Glasgow G12 8QQ

First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark

21 January 2025 – Copenhagen, Denmark – CSL Behring Denmark today announced that the first Danish patients with haemophilia B were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec). HEMGENIX®...

Category:
Posted: January 21, 2025

CSL Global Headquarters, 655 Elizabeth Street, Melbourne VIC 3000 Australia

Avery Dennison and partners to showcase RFID-enabled digital ID solution for pre-filled syringe traceability at Pharmapack 2025

16 January 2025 – Mentor, OH, US – Avery Dennison has announced its plans for Pharmapack 2025, which includes showcasing a groundbreaking RFID (radio frequency identification) pre-filled syringe (PFS) authentication...

Category: Drug Delivery, Manufacturing and Packing
Posted: January 20, 2025

8080 Norton Parkway Mentor, Ohio 44060

Cymphony is urgently advocating for improved communication to meet the rapidly growing demand from Gen Z and Millennial patients

Now more than ever, patients are seeking timely and efficient ways to communicate with their healthcare providers 20 January 2025 -- Crewe, UK -- Given the recent uptick in private...

Category: Logistics, Other, Pharmaceutical
Posted: January 20, 2025

Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain’s fastest-growing private technology companies

Inaugural feature recognises companies within the UK technology sector, developing or selling a proprietary technology Listing is recognition of Metrion’s leadership position in preclinical ion channel drug discovery research services...

Category: Biotechnology
Posted: January 20, 2025

Metrion Biosciences Building, B501 Babraham, Research Campus, Cambridge, CB22 3AT, UK

BD Highlights the Latest Innovations in Drug Delivery at Pharmapack 2025

20 January 2025 -- New Jersey, US -- BD (Becton, Dickinson and Company), a leading global medical technology company, will showcase a wide range of cutting-edge drug delivery innovations at...

Category: Biotechnology, Drug Delivery, Logistics, Other, Pharmaceutical
Posted: January 20, 2025

1 Becton Drive Franklin Lakes, NJ 07417-1880

Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round

Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures Funding will be used to accelerate commercialization and further clinical trials of...

Category: Drug Discovery
Posted: January 17, 2025

Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK

Nipro and Nemera Prove Compatibility of Unit-Dose™ Microvials and UniSpray

16 January 2025 – Lyon, France – Nipro and Nemera Prove Compatibility of Unit-Dose™ Microvials and UniSpray Nipro PharmaPackaging and Nemera are pleased to announce the successful compatibility testing of...

Category: Manufacturing and Packing, Pharmaceutical
Posted: January 16, 2025

63 avenue Tony Garnier 69007